Literature DB >> 15121044

Ezrin, a key component in tumor metastasis.

Kent W Hunter1.   

Abstract

Identification of the key regulatory molecules in metastasis is crucial for understanding tumor dissemination and for the development of novel interventions. The recent identification of ezrin as a necessary component in the metastasis of osteosarcoma and rhabdomyosarcoma is, therefore, an important advance. Ezrin has been implicated in many roles, for example, as a conduit for signals between metastasis-associated cell-surface molecules and signal transduction components. This suggests that ezrin and, potentially, other members of the ERM (ezrin-radixin-moesin) family have key roles in the coordination of signals and cellular complexes that are required for the successful metastasis of these and other malignancies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121044     DOI: 10.1016/j.molmed.2004.03.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  82 in total

Review 1.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

2.  Backbone resonance assignments of Ezrin C ERMAD in a non-covalent complex with Ezrin N FERM.

Authors:  Bhargavi Jayaraman; Linda K Nicholson
Journal:  J Biomol NMR       Date:  2006       Impact factor: 2.835

3.  Proteomics analysis of the ezrin interactome in B cells reveals a novel association with Myo18aα.

Authors:  Ken Matsui; Neetha Parameswaran; Nayer Bagheri; Belinda Willard; Neetu Gupta
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

4.  Increase in ezrin expression from benign to malignant breast tumours.

Authors:  Daphne Gschwantler-Kaulich; Camilla Natter; Stefan Steurer; Ingrid Walter; Almut Thomas; Mohamed Salama; Christian F Singer
Journal:  Cell Oncol (Dordr)       Date:  2013-10-16       Impact factor: 6.730

5.  Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro.

Authors:  Qing-Yong Chen; Wei Xu; De-Min Jiao; Li-Jun Wu; Jia Song; Jie Yan; Jian-Guo Shi
Journal:  Mol Cell Biochem       Date:  2013-02-22       Impact factor: 3.396

6.  Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase.

Authors:  Jinyang Gu; Shu Zhang; Xingyu Wu; Jiong Shi; Bin Zhang; Xiaoqi Zhang; Jun Yang; Halmurat Obulkasim; Fei Duan; Chao Deng; Jing He; Xiaoping Zou; Yitao Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

7.  MicroRNA-150 upregulation reduces osteosarcoma cell invasion and metastasis by downregulating Ezrin.

Authors:  Ce Zhan; Cheng Li; Hao Zhang; Hao Tang; Fang Ji; Su-Chi Qiao; Wei-Dong Xu; Zhi-Wei Wang
Journal:  Oncol Lett       Date:  2016-08-25       Impact factor: 2.967

Review 8.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

9.  Regulation of Son of sevenless by the membrane-actin linker protein ezrin.

Authors:  Katja J Geissler; M Juliane Jung; Lars Björn Riecken; Tobias Sperka; Yan Cui; Stephan Schacke; Ulrike Merkel; Robby Markwart; Ignacio Rubio; Manuel E Than; Constanze Breithaupt; Sebastian Peuker; Reinhard Seifert; Ulrich Benjamin Kaupp; Peter Herrlich; Helen Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma.

Authors:  Chun-Nan Yeh; See-Tong Pang; Tsung-Wen Chen; Ren-Ching Wu; Wen-Hui Weng; Miin-Fu Chen
Journal:  BMC Cancer       Date:  2009-07-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.